Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
20.40
+2.26 (12.46%)
May 2, 2025, 4:08 PM HKT
HKG:2190 Revenue
In the year 2024, Zylox-Tonbridge Medical Technology had annual revenue of 782.48M CNY with 48.27% growth. Zylox-Tonbridge Medical Technology had revenue of 416.49M in the half year ending December 31, 2024, with 129.66% growth.
Revenue
782.48M CNY
Revenue Growth
+48.27%
P/S Ratio
7.82
Revenue / Employee
894.26K CNY
Employees
875
Market Cap
6.52B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Innovent Biologics | 10.03B |
Alibaba Health Information Technology | 31.39B |
Akeso | 2.26B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |